Title: 
Official Title: To direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color.
Number of Sections: 2
Source: versions - Introduced in Senate
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Uterine Cancer Study Act of 2025.

Section 2:
2.Study on relationship between hair straighteners and uterine cancer(a)StudyThe Secretary, in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health, shall conduct a study on the relationship between hair straighteners and uterine cancer, with a focus on the increased incidence of such cancer among women of color. Such study shall—(1)review significant findings and recommendations from other studies regarding the relationship between hair straighteners and uterine cancer;(2)consider impacts on women and other individuals at risk of uterine cancer from all racial and ethnic backgrounds;(3)disaggregate the results of the study under this section according to whether the hair straighteners contain dyes or coloring, bleach, highlights, or perms; and(4)determine whether the Food and Drug Administration should impose additional testing requirements on the manufacturers of hair straightening products to ensure the safety of such products.(b)MethodologyNot later than 45 days after the date of enactment of this Act, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a description of the methodology that will be used to conduct the study under this section.(c)CommencementNot later than 180 days after the date of enactment of this Act, the Secretary shall commence the study under this section.(d)ReportNot later than 2 years after the date of enactment of this Act, the Secretary shall complete the study under this section and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the results of such study.(e)DefinitionIn this section:(1)Hair straightenerThe term hair straightener means a chemical hair straightener.(2)SecretaryThe term Secretary means the Secretary of Health and Human Services.


================================================================================

Raw Text:
119 S2285 IS: Uterine Cancer Study Act of 2025
U.S. Senate
2025-07-15
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



II119th CONGRESS1st SessionS. 2285IN THE SENATE OF THE UNITED STATESJuly 15, 2025Ms. Blunt Rochester introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and PensionsA BILLTo direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color.1.Short titleThis Act may be cited as the Uterine Cancer Study Act of 2025.2.Study on relationship between hair straighteners and uterine cancer(a)StudyThe Secretary, in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health, shall conduct a study on the relationship between hair straighteners and uterine cancer, with a focus on the increased incidence of such cancer among women of color. Such study shall—(1)review significant findings and recommendations from other studies regarding the relationship between hair straighteners and uterine cancer;(2)consider impacts on women and other individuals at risk of uterine cancer from all racial and ethnic backgrounds;(3)disaggregate the results of the study under this section according to whether the hair straighteners contain dyes or coloring, bleach, highlights, or perms; and(4)determine whether the Food and Drug Administration should impose additional testing requirements on the manufacturers of hair straightening products to ensure the safety of such products.(b)MethodologyNot later than 45 days after the date of enactment of this Act, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a description of the methodology that will be used to conduct the study under this section.(c)CommencementNot later than 180 days after the date of enactment of this Act, the Secretary shall commence the study under this section.(d)ReportNot later than 2 years after the date of enactment of this Act, the Secretary shall complete the study under this section and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the results of such study.(e)DefinitionIn this section:(1)Hair straightenerThe term hair straightener means a chemical hair straightener.(2)SecretaryThe term Secretary means the Secretary of Health and Human Services.